July 30, 2018:  Congratulations to Dr. Ware Kuschner, who in addition to being Section Chief at the VA Palo Alto, has been made the Associate Chief for PCCM Faculty Affairs.

April 10, 2018:  Congratulations to Dr. Harmeet Bedi in winning the 2018 PCCM Teaching Award.  Dr. Bedi is a beloved teacher of interventional pulmonology. He is widely revered for his consistent, predictable, engaged and effective didactic sessions in the bronchoscopy suite. New pulmonary fellows can expect to be thoroughly educated with lung anatomy (from the inside-out), cutting-edge pulmonary procedures and their therapeutic maneuvers. 

March 7, 2018:  Congratulations to Dr. Meghan Ramsey for representing the PCCM division as the Quality Director.   

February 21, 2018:  Congratulations to Dr. Tushar Desai.  He has published field-changing work on a new automated cell-type classification in intact tissues by single-cell molecular profiling. PLISH is set to revolutionize biomedicine! (Elife January 2018)

To cap this off, Tushar also has a new high impact study evaluating the stem-cell properties of lung cells. (Science February 2018).

February 21, 2018:  Congratulations to Dr. Joe Hsu, lead author of the study titled "Microhemorrhage-associated tissue iron enhances the risk for Aspergillus fumigatus invasion in a mouse model of airway transplantation", which was reported February 21 in Science Translational Medicine.

January 24, 2018:  Dr. Arthur Sung leads the Pulmonary & Critical Care Medicine expansion into Emeryville.


December 20, 2017:  Congratulations to Nicholas Juul who has been awarded a School of Medicine Dean’s Postdoctoral Fellowship for his postdoctoral research titled: “The function and temporal variation of Wnt signaling in idiopathic pulmonary fibrosis” under the mentorship of Dr. Tushar Desai.

October 18, 2017:  Congratulations to Dr. Vinicio de Jesus Perez who has been awarded his second NIH R01 grant dealing with mechanisms of pulmonary arterial hypertension.

September 21, 2017:  Big congratulations to Marlene Rabinovitch, MD and Roham Zamanian, MD, FCCP for a major 5 year extension to their translational P01 grant evaluating the action and efficacy of the neutrophil elastase inhibitor, elafin, in pulmonary arterial hypertension (PAH)!  This second phase of the 10-year P01 grant will bring forward elafin as a new potential therapy for PAH, a life-threatening condition currently without a cure.  We are proud of our long and close affiliation with Marlene, who continues to champion research and provide invaluable mentorship to our fellows and junior faculty.  This grant is also a testament to the leadership of Roham Zamanian who has been instrumental in developing one of the great clinical pulmonary vascular programs in the country.  Please congratulate Marlene and Roham when you see them (along with Michal Roof, PhD and Michelle Fox who helped so much behind the scenes to make this grant happen).

September 21, 2017: Big congratulations to Marlene Rabinovitch, MD and Roham Zamanian, MD, FCCP for a major 5 year extension to their translational P01 grant evaluating the action and efficacy of the neutrophil elastase inhibitor, elafin, in pulmonary arterial hypertension (PAH)!...

August 16, 2017:  Congratulations to one of our 'extended' family members, Marlene Rabinovitch, MD, who has been a mentor, colleague and friend to the Division for years.  She has been named the AHA Distinguished Scientist Lecturer for the Annual AHA Meeting in Anaheim this year.  This is a signal acknowledgment, made even more remarkable by her winning the Amberson Lectureship at the ATS last year. These awards reflect the high regard towards Marlene held by academic physicians and physician-scientists.

June 27, 2017:  Congratulations to Postdoctural Fellow, Dr. Monica Romero Lopez on being awarded the School of Medicine Dean’s Postdoctoral Fellowship award for her proposal titled:  “Wnt7a: A Novel Regulator of Right Ventricular Adaption in Pulmonary Arterial Hypertension” under the mentorship of Dr. Vinicio de Jesus Perez.  The Dean’s Postdoctoral Fellowship at the School of Medicine is a longstanding program in support of postdoctoral research.

June 27, 2017:  Congratulations to Instructor, Dr. Sandra Andorf on being awarded the Child Health Research Institute (CHRI) Grant & Postdoctural Award for her proposal titled:  “Characterizing natural tolerance in milk and egg allergic Children and their implications” under the mentorship of Dr. Kari Nadeau.  CHRI at Stanford University provides a unique opportunity to advance the health of children and expectant mothers worldwide.

June 14, 2017:  Congratulations to our PCCM Division Chief, Dr. Mark Nicolls and Dr. Marlene Rabinovitch for a new $3M NIH/NHLBI R01 grant entitled "Endothelial Injury, BMPR2 Dysfunction and Macrophage Activation Cause Endothelial-Mesenchymal Transition and Pulmonary Arterial Hypertension". The proposed studies will investigate how inflammation causes vascular injury that culminates in a deadly pulmonary disease for which there is currently no curative therapy.

June 14, 2017:  The Pulmonary & Critical Care Medicine Division is happy to formally announce that Dr. Chitra Dinakar is the new Clinical Chief of Allergy and Asthma in PCCM.  Professor Dinakar was recruited to Stanford as part of the Sean N. Parker Center led by Dr. Kari Nadeau. Chitra is a national leader in the field and was recently elected to the American Academy of Allergy, Asthma & Immunology’s Board of Directors in March of this year.  Chitra will help lead the burgeoning allergy and asthma clinical programs which began with the arrival of Kari and her team into our division. Please welcome Chitra when you see her!

June 12, 2017:  Congratulations to Amy Tian, PhD, who has been awarded the Top Poster at the Lymphatic Forum 2017 in Chicago! This was a highly competitive process and was based on a study just published in Science Translational Medicine. Amy's work describes how inflammation contributes to lymphedema, a chronic condition affecting millions for which there are no approved medical treatments. For her achievement, Dr. Tian will receive a $1,000 prize. Her work served as the basis of a new and currently enrolling clinical trial (ULTRA) which specifically targets lymphedema-associated inflammation with a new drug therapy.